Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Withdrawn × GRN163L peptide × 30 days × Clear all

Status

Sponsor

Interventions

pembrolizumab 3 Cyclophosphamide 3 fludarabine phosphate 2 fludarabine 2 tremelimumab 1 regorafenib 1 olaparib 1 enfortumab vedotin 1 durvalumab 1 decitabine and cedazuridine drug combination 1 atezolizumab 1 aldesleukin 1 Whole-Body Irradiation 1 Transcranial Direct Current Stimulation 1 Tiragolumab 1 Stem Cell Transplantation 1 Sirolimus 1 Restraint, Physical 1 Radiosurgery 1 Phantoms, Imaging 1 Paclitaxel 1 Mycophenolic Acid 1 Metformin 1 Mesna 1 Magnetic Resonance Spectroscopy 1 Interleukin-2 1 Human Papillomavirus DNA Tests 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Epirubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡